Methylprednisolone Sodium Succinate

• Stroke in childhood due to inflammatory narrowing of blood vessels: Treatment with steroids Pending
  2022-500631-36-00 Phase III 5 countries Insel Gruppe AG
• A PROJECT FOR TWO MULTICENTRE, PROSPECTIVE OPEN LABEL RANDOMIZED CLINICAL STUDIES TO EVALUATE THE EFFECT OF TARGETED THERAPY BASED ON KIDNEY… Pending
  2024-517861-18-00 Phase III 1 country Fondazione Schena Centro Europeo Della Ricerca Sulle Malattie Renali
• Multi-Center, Open Label Gene Therapy Study of RP-A501 in Male Patients with Danon Disease Recruiting
  2023-506480-34-00 Phase II 2 countries Rocket Pharmaceuticals Inc.
• Use of tacrolimus and MTOR inhibitors with anticipatory therapy vs. tacrolimus and mycophenolic acid in renal recipients at high risk of pos… Recruiting
  2025-520854-12-00 Phase IV 1 country Hospital Universitario La Paz
• Myocarditis Therapy with Steroids in patients with a Mildly Reduced ejection fraction (MYTHS-MR) Recruiting
  2022-501547-33-01 Phase III/IV 4 countries Antwerp University Hospital
• Trial to assess the safety and efficacy of high dose pulse intravenous corticosteroid therapy to treat patients with complicated/fulminant a… Recruiting
  2023-504169-22-02 Phase III 7 countries ASST Grande Ospedale Metropolitano Niguarda
• A clinical trial applying Regulatory T cells in kidney transplant recipients to investigate the safety and tolerability as an adjunctive the… Recruiting
  2024-514398-23-00 Phase I/II 1 country Charite Universitaetsmedizin Berlin KöR
• The study's aim is to treat adult patients affected by Ph-like ALL, a Philadelphianegative ALL subtype, with a combination of the tyrosine k… Recruiting
  2023-510240-20-00 Phase II 1 country Fondazione Gimema Franco Mandelli Onlus
• A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia Recruiting
  2022-501050-11-01 Phase II/III 14 countries Karolinska University Hospital
• ICC APL STUDY 02 Treatment study for children and adolescents with Acute Promyelocytic Leukemia Ended
  2024-518669-83-00 Phase II 5 countries Associazione Italiana Ematologia Oncologia Pediatrica
• Study to treat adult patients with Very High-Risk T-cell Acute Lymphoblastic Leukemia (ALL) with Daratumumab in addition to the National ALL… Ended
  2024-511627-34-00 Phase II 1 country Fondazione Gimema Franco Mandelli Onlus
• A Study to Evaluate Safety and Efficacy of Ocrelizumab in Comparison with Fingolimod in Children and Adolescents with Relapsing-Remitting Mu… Ended
  2023-506516-40-00 Phase III 17 countries F. Hoffmann-La Roche AG
• The study aims to verify the greater efficacy of the treatment of Acute Lymphoblastic Leukemia Ph + through the combination of Ponatinib and… Ended
  2023-508968-30-00 Phase III 1 country Fondazione Gimema Franco Mandelli Onlus
• A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults with Primary Progressive Multiple Sclerosis Ended
  2023-505980-36-00 Phase III 9 countries F. Hoffmann-La Roche AG
• A Study of Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis (PALIZADE) Ended
  2022-502227-22-00 Phase II 7 countries Kezar Life Sciences Inc.
• Obinutuzumab for primary membranous nephropathy: a pilot study in patients with rituximab-resistant or rituximab-dependent nephrotic syndrom… Ended
  2024-515857-93-00 Phase II 1 country Istituto Di Ricerche Farmacologiche Mario Negri

Showing 1–16 of 16 trials